Associated Banc-Corp
- SEC CIK
- 0000007789
- Latest filing
- Jul 31, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by Associated Banc-Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 59,627
- Value
- $71.5M
- % of portfolio
- 1.7%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 59,627 | $71.5M | 1.7% | +564+1.0% | Added | Holders |
| Q1 2026 | 59,063 | $54.3M | 1.4% | +1,027+1.8% | Added | Holders |
| Q4 2025 | 58,036 | $62.4M | 1.6% | +1,398+2.5% | Added | Holders |
| Q3 2025 | 56,638 | $43.2M | 1.1% | +1,272+2.3% | Added | Holders |
| Q2 2025 | 55,366 | $43.2M | 1.2% | +869+1.6% | Added | Holders |
| Q1 2025 | 54,497 | $45.0M | 1.4% | +3,094+6.0% | Added | Holders |
| Q4 2024 | 51,403 | $39.7M | 1.2% | +25,104+95.5% | Added | Holders |
| Q3 2024 | 26,299 | $23.3M | 0.7% | +3,197+13.8% | Added | Holders |
| Q2 2024 | 23,102 | $20.9M | 0.7% | +2,549+12.4% | Added | Holders |
| Q1 2024 | 20,553 | $16.0M | 0.5% | +2,187+11.9% | Added | Holders |
| Q4 2023 | 18,366 | $10.7M | 0.4% | +1,919+11.7% | Added | Holders |
| Q3 2023 | 16,447 | $8.83M | 0.3% | −123−0.7% | Reduced | Holders |
| Q2 2023 | 16,570 | $7.77M | 0.3% | −50.0% | Reduced | Holders |
| Q1 2023 | 16,575 | $5.69M | 0.2% | +112+0.7% | Added | Holders |
| Q4 2022 | 16,463 | $6.02M | 0.3% | −34−0.2% | Reduced | Holders |
| Q3 2022 | 16,497 | $5.33M | 0.2% | +30+0.2% | Added | Holders |
| Q2 2022 | 16,467 | $5.34M | 0.2% | +10+0.1% | Added | Holders |
| Q1 2022 | 16,457 | $4.71M | 0.2% | −30−0.2% | Reduced | Holders |
| Q4 2021 | 16,487 | $4.55M | 0.2% | +405+2.5% | Added | Holders |
| Q3 2021 | 16,082 | $3.72M | 0.1% | −31−0.2% | Reduced | Holders |
| Q2 2021 | 16,113 | $3.70M | 0.1% | −1,277−7.3% | Reduced | Holders |
| Q1 2021 | 17,390 | $2.41M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.